Selected research
Industry Growth & Trends
Global Active Pharmaceutical Ingredient Excipient Industry Growth and Trends Forecast to 2032
Market perspective
The global Active Pharmaceutical Ingredient Excipient market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Active Pharmaceutical Ingredient Excipient is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Active Pharmaceutical Ingredient Excipient is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Active Pharmaceutical Ingredient Excipient is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Active Pharmaceutical Ingredient Excipient include BASF, Roquette Freres, DuPont, Dow, Croda Health Care, Colorcon and Ashland, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Active Pharmaceutical Ingredient Excipient market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Active Pharmaceutical Ingredient Excipient market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Active Pharmaceutical Ingredient Excipient market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Active Pharmaceutical Ingredient Excipient.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Active Pharmaceutical Ingredient Excipient market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Active Pharmaceutical Ingredient Excipient Market by Company
BASF
Roquette Freres
DuPont
Dow
Croda Health Care
Colorcon
Ashland
Active Pharmaceutical Ingredient Excipient Segment by Type
Synthetic Chemical APIs
Natural Chemical APIs
Active Pharmaceutical Ingredient Excipient Segment by Application
Topical Formulations
Oral Formulations
Parenteral Formulations
Other
Active Pharmaceutical Ingredient Excipient Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Active Pharmaceutical Ingredient Excipient market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Active Pharmaceutical Ingredient Excipient and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Active Pharmaceutical Ingredient Excipient.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Active Pharmaceutical Ingredient Excipient manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Active Pharmaceutical Ingredient Excipient in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
List of Tables
Table 1. Major Company of Synthetic Chemical APIs
Table 2. Major Company of Natural Chemical APIs
Table 3. Global Active Pharmaceutical Ingredient Excipient Sales by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Global Active Pharmaceutical Ingredient Excipient Sales by Type (2021-2026) & (Kg)
Table 5. Global Active Pharmaceutical Ingredient Excipient Sales Market Share in Volume by Type (2021-2026)
Table 6. Global Active Pharmaceutical Ingredient Excipient Sales by Type (2021-2026) & (US$ Million)
Table 7. Global Active Pharmaceutical Ingredient Excipient Sales Market Share in Value by Type (2021-2026)
Table 8. Global Active Pharmaceutical Ingredient Excipient Price by Type (2021-2026) & (US$/Kg)
Table 9. Global Active Pharmaceutical Ingredient Excipient Sales by Type (2027-2032) & (Kg)
Table 10. Global Active Pharmaceutical Ingredient Excipient Sales Market Share in Volume by Type (2027-2032)
Table 11. Global Active Pharmaceutical Ingredient Excipient Sales by Type (2027-2032) & (US$ Million)
Table 12. Global Active Pharmaceutical Ingredient Excipient Sales Market Share in Value by Type (2027-2032)
Table 13. Global Active Pharmaceutical Ingredient Excipient Price by Type (2027-2032) & (US$/Kg)
Table 14. North America Active Pharmaceutical Ingredient Excipient Sales by Type (2021-2026) & (Kg)
Table 15. North America Active Pharmaceutical Ingredient Excipient Sales by Type (2021-2026) & (US$ Million)
Table 16. Europe Active Pharmaceutical Ingredient Excipient Sales by Type (2021-2026) & (Kg)
Table 17. Europe Active Pharmaceutical Ingredient Excipient Sales by Type (2021-2026) & (US$ Million)
Table 18. Asia-Pacific Active Pharmaceutical Ingredient Excipient Sales by Type (2021-2026) & (Kg)
Table 19. Asia-Pacific Active Pharmaceutical Ingredient Excipient Sales by Type (2021-2026) & (US$ Million)
Table 20. Latin America Active Pharmaceutical Ingredient Excipient Sales by Type (2021-2026) & (Kg)
Table 21. Latin America Active Pharmaceutical Ingredient Excipient Sales by Type (2021-2026) & (US$ Million)
Table 22. Middle East and Africa Active Pharmaceutical Ingredient Excipient Sales by Type (2021-2026) & (Kg)
Table 23. Middle East and Africa Active Pharmaceutical Ingredient Excipient Sales by Type (2021-2026) & (US$ Million)
Table 24. Active Pharmaceutical Ingredient Excipient Industry Trends
Table 25. Active Pharmaceutical Ingredient Excipient Industry Drivers
Table 26. Active Pharmaceutical Ingredient Excipient Industry Opportunities and Challenges
Table 27. Active Pharmaceutical Ingredient Excipient Industry Restraints
Table 28. Global Active Pharmaceutical Ingredient Excipient Sales Revenue by Company (US$ Million) & (2021-2026)
Table 29. Global Active Pharmaceutical Ingredient Excipient Revenue Market Share by Company (2021-2026)
Table 30. Global Active Pharmaceutical Ingredient Excipient Sales by Company (2021-2026) & (Kg)
Table 31. Global Active Pharmaceutical Ingredient Excipient Sales Share by Company (2021-2026)
Table 32. Global Active Pharmaceutical Ingredient Excipient Market Price by Company (2021-2026) & (US$/Kg)
Table 33. Global Active Pharmaceutical Ingredient Excipient Industry Company Ranking, 2024 VS 2025 VS 2026
Table 34. Global Active Pharmaceutical Ingredient Excipient Major Company Production Sites and Headquarters
Table 35. Global Active Pharmaceutical Ingredient Excipient Company, Product Type & Application
Table 36. Global Active Pharmaceutical Ingredient Excipient Company Establishment Date
Table 37. Global Company Market Concentration Ratio (CR5 and HHI)
Table 38. Global Active Pharmaceutical Ingredient Excipient by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 39. Global Active Pharmaceutical Ingredient Excipient Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032
Table 40. Global Active Pharmaceutical Ingredient Excipient Sales by Region (2021-2026) & (Kg)
Table 41. Global Active Pharmaceutical Ingredient Excipient Sales Market Share in Volume by Region (2021-2026)
Table 42. Global Active Pharmaceutical Ingredient Excipient Sales by Region (2021-2026) & (US$ Million)
Table 43. Global Active Pharmaceutical Ingredient Excipient Sales Market Share in Value by Region (2021-2026)
Table 44. Global Active Pharmaceutical Ingredient Excipient Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 45. Global Active Pharmaceutical Ingredient Excipient Sales by Region (2027-2032) & (Kg)
Table 46. Global Active Pharmaceutical Ingredient Excipient Sales Market Share in Volume by Region (2027-2032)
Table 47. Global Active Pharmaceutical Ingredient Excipient Sales by Region (2027-2032) & (US$ Million)
Table 48. Global Active Pharmaceutical Ingredient Excipient Sales Market Share in Value by Region (2027-2032)
Table 49. Global Active Pharmaceutical Ingredient Excipient Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2027-2032)
Table 50. Global Active Pharmaceutical Ingredient Excipient Sales by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 51. Global Active Pharmaceutical Ingredient Excipient Sales by Application (2021-2026) & (Kg)
Table 52. Global Active Pharmaceutical Ingredient Excipient Sales Market Share in Volume by Application (2021-2026)
Table 53. Global Active Pharmaceutical Ingredient Excipient Sales by Application (2021-2026) & (US$ Million)
Table 54. Global Active Pharmaceutical Ingredient Excipient Sales Market Share in Value by Application (2021-2026)
Table 55. Global Active Pharmaceutical Ingredient Excipient Price by Application (2021-2026) & (US$/Kg)
Table 56. Global Active Pharmaceutical Ingredient Excipient Sales by Application (2027-2032) & (Kg)
Table 57. Global Active Pharmaceutical Ingredient Excipient Sales Market Share in Volume by Application (2027-2032)
Table 58. Global Active Pharmaceutical Ingredient Excipient Sales by Application (2027-2032) & (US$ Million)
Table 59. Global Active Pharmaceutical Ingredient Excipient Sales Market Share in Value by Application (2027-2032)
Table 60. Global Active Pharmaceutical Ingredient Excipient Price by Application (2027-2032) & (US$/Kg)
Table 61. North America Active Pharmaceutical Ingredient Excipient Sales by Application (2021-2026) & (Kg)
Table 62. North America Active Pharmaceutical Ingredient Excipient Sales by Application (2021-2026) & (US$ Million)
Table 63. Europe Active Pharmaceutical Ingredient Excipient Sales by Application (2021-2026) & (Kg)
Table 64. Europe Active Pharmaceutical Ingredient Excipient Sales by Application (2021-2026) & (US$ Million)
Table 65. Asia-Pacific Active Pharmaceutical Ingredient Excipient Sales by Application (2021-2026) & (Kg)
Table 66. Asia-Pacific Active Pharmaceutical Ingredient Excipient Sales by Application (2021-2026) & (US$ Million)
Table 67. Latin America Active Pharmaceutical Ingredient Excipient Sales by Application (2021-2026) & (Kg)
Table 68. Latin America Active Pharmaceutical Ingredient Excipient Sales by Application (2021-2026) & (US$ Million)
Table 69. Middle East and Africa Active Pharmaceutical Ingredient Excipient Sales by Application (2021-2026) & (Kg)
Table 70. Middle East and Africa Active Pharmaceutical Ingredient Excipient Sales by Application (2021-2026) & (US$ Million)
Table 71. BASF Company Information
Table 72. BASF Business Overview
Table 73. BASF Active Pharmaceutical Ingredient Excipient Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 74. BASF Active Pharmaceutical Ingredient Excipient Product Portfolio
Table 75. BASF Recent Development
Table 76. Roquette Freres Company Information
Table 77. Roquette Freres Business Overview
Table 78. Roquette Freres Active Pharmaceutical Ingredient Excipient Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 79. Roquette Freres Active Pharmaceutical Ingredient Excipient Product Portfolio
Table 80. Roquette Freres Recent Development
Table 81. DuPont Company Information
Table 82. DuPont Business Overview
Table 83. DuPont Active Pharmaceutical Ingredient Excipient Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 84. DuPont Active Pharmaceutical Ingredient Excipient Product Portfolio
Table 85. DuPont Recent Development
Table 86. Dow Company Information
Table 87. Dow Business Overview
Table 88. Dow Active Pharmaceutical Ingredient Excipient Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 89. Dow Active Pharmaceutical Ingredient Excipient Product Portfolio
Table 90. Dow Recent Development
Table 91. Croda Health Care Company Information
Table 92. Croda Health Care Business Overview
Table 93. Croda Health Care Active Pharmaceutical Ingredient Excipient Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 94. Croda Health Care Active Pharmaceutical Ingredient Excipient Product Portfolio
Table 95. Croda Health Care Recent Development
Table 96. Colorcon Company Information
Table 97. Colorcon Business Overview
Table 98. Colorcon Active Pharmaceutical Ingredient Excipient Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 99. Colorcon Active Pharmaceutical Ingredient Excipient Product Portfolio
Table 100. Colorcon Recent Development
Table 101. Ashland Company Information
Table 102. Ashland Business Overview
Table 103. Ashland Active Pharmaceutical Ingredient Excipient Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 104. Ashland Active Pharmaceutical Ingredient Excipient Product Portfolio
Table 105. Ashland Recent Development
Table 106. North America Active Pharmaceutical Ingredient Excipient Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032
Table 107. North America Active Pharmaceutical Ingredient Excipient Sales by Country (2021-2026) & (Kg)
Table 108. North America Active Pharmaceutical Ingredient Excipient Sales Market Share by Country (2021-2026)
Table 109. North America Active Pharmaceutical Ingredient Excipient Sales Forecast by Country (2027-2032) & (Kg)
Table 110. North America Active Pharmaceutical Ingredient Excipient Sales Market Share Forecast by Country (2027-2032)
Table 111. North America Active Pharmaceutical Ingredient Excipient Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 112. North America Active Pharmaceutical Ingredient Excipient Market Size by Country (2021-2026) & (US$ Million)
Table 113. North America Active Pharmaceutical Ingredient Excipient Market Share by Country (2021-2026)
Table 114. North America Active Pharmaceutical Ingredient Excipient Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 115. North America Active Pharmaceutical Ingredient Excipient Market Share Forecast by Country (2027-2032)
Table 116. Europe Active Pharmaceutical Ingredient Excipient Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032
Table 117. Europe Active Pharmaceutical Ingredient Excipient Sales by Country (2021-2026) & (Kg)
Table 118. Europe Active Pharmaceutical Ingredient Excipient Sales Market Share by Country (2021-2026)
Table 119. Europe Active Pharmaceutical Ingredient Excipient Sales Forecast by Country (2027-2032) & (Kg)
Table 120. Europe Active Pharmaceutical Ingredient Excipient Sales Market Share Forecast by Country (2027-2032)
Table 121. Europe Active Pharmaceutical Ingredient Excipient Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 122. Europe Active Pharmaceutical Ingredient Excipient Market Size by Country (2021-2026) & (US$ Million)
Table 123. Europe Active Pharmaceutical Ingredient Excipient Market Share by Country (2021-2026)
Table 124. Europe Active Pharmaceutical Ingredient Excipient Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 125. Europe Active Pharmaceutical Ingredient Excipient Market Share Forecast by Country (2027-2032)
Table 126. Asia-Pacific Active Pharmaceutical Ingredient Excipient Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032
Table 127. Asia-Pacific Active Pharmaceutical Ingredient Excipient Sales by Country (2021-2026) & (Kg)
Table 128. Asia-Pacific Active Pharmaceutical Ingredient Excipient Sales Market Share by Country (2021-2026)
Table 129. Asia-Pacific Active Pharmaceutical Ingredient Excipient Sales Forecast by Country (2027-2032) & (Kg)
Table 130. Asia-Pacific Active Pharmaceutical Ingredient Excipient Sales Market Share Forecast by Country (2027-2032)
Table 131. Asia-Pacific Active Pharmaceutical Ingredient Excipient Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 132. Asia-Pacific Active Pharmaceutical Ingredient Excipient Market Size by Country (2021-2026) & (US$ Million)
Table 133. Asia-Pacific Active Pharmaceutical Ingredient Excipient Market Share by Country (2021-2026)
Table 134. Asia-Pacific Active Pharmaceutical Ingredient Excipient Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 135. Asia-Pacific Active Pharmaceutical Ingredient Excipient Market Share Forecast by Country (2027-2032)
Table 136. Latin America Active Pharmaceutical Ingredient Excipient Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032
Table 137. Latin America Active Pharmaceutical Ingredient Excipient Sales by Country (2021-2026) & (Kg)
Table 138. Latin America Active Pharmaceutical Ingredient Excipient Sales Market Share by Country (2021-2026)
Table 139. Latin America Active Pharmaceutical Ingredient Excipient Sales Forecast by Country (2027-2032) & (Kg)
Table 140. Latin America Active Pharmaceutical Ingredient Excipient Sales Market Share Forecast by Country (2027-2032)
Table 141. Latin America Active Pharmaceutical Ingredient Excipient Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 142. Latin America Active Pharmaceutical Ingredient Excipient Market Size by Country (2021-2026) & (US$ Million)
Table 143. Latin America Active Pharmaceutical Ingredient Excipient Market Share by Country (2021-2026)
Table 144. Latin America Active Pharmaceutical Ingredient Excipient Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 145. Latin America Active Pharmaceutical Ingredient Excipient Market Share Forecast by Country (2027-2032)
Table 146. Middle East and Africa Active Pharmaceutical Ingredient Excipient Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032
Table 147. Middle East and Africa Active Pharmaceutical Ingredient Excipient Sales by Country (2021-2026) & (Kg)
Table 148. Middle East and Africa Active Pharmaceutical Ingredient Excipient Sales Market Share by Country (2021-2026)
Table 149. Middle East and Africa Active Pharmaceutical Ingredient Excipient Sales Forecast by Country (2027-2032) & (Kg)
Table 150. Middle East and Africa Active Pharmaceutical Ingredient Excipient Sales Market Share Forecast by Country (2027-2032)
Table 151. Middle East and Africa Active Pharmaceutical Ingredient Excipient Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 152. Middle East and Africa Active Pharmaceutical Ingredient Excipient Market Size by Country (2021-2026) & (US$ Million)
Table 153. Middle East and Africa Active Pharmaceutical Ingredient Excipient Market Share by Country (2021-2026)
Table 154. Middle East and Africa Active Pharmaceutical Ingredient Excipient Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 155. Middle East and Africa Active Pharmaceutical Ingredient Excipient Market Share Forecast by Country (2027-2032)
Table 156. Key Raw Materials
Table 157. Raw Materials Key Suppliers
Table 158. Active Pharmaceutical Ingredient Excipient Distributors List
Table 159. Active Pharmaceutical Ingredient Excipient Customers List
Table 160. Research Programs/Design for This Report
Table 161. Authors List of This Report
Table 162. Secondary Sources
Table 163. Primary Sources
List of Figures
Figure 1. Active Pharmaceutical Ingredient Excipient Image
Figure 2. Global Active Pharmaceutical Ingredient Excipient Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Active Pharmaceutical Ingredient Excipient Market Size (2021-2032) & (US$ Million)
Figure 4. Global Active Pharmaceutical Ingredient Excipient Sales (2021-2032) & (Kg)
Figure 5. Synthetic Chemical APIs Image
Figure 6. Global Synthetic Chemical APIs Sales YoY Growth (2021-2032) & (Kg)
Figure 7. Natural Chemical APIs Image
Figure 8. Global Natural Chemical APIs Sales YoY Growth (2021-2032) & (Kg)
Figure 9. Global Active Pharmaceutical Ingredient Excipient Market Size Overview by Type (2021-2032) & (US$ Million)
Figure 10. Global Active Pharmaceutical Ingredient Excipient Market Share by Type 2025 VS 2032
Figure 11. North America Active Pharmaceutical Ingredient Excipient Sales Market Share in Volume by Type in 2025
Figure 12. North America Active Pharmaceutical Ingredient Excipient Sales Market Share in Value by Type in 2025
Figure 13. Europe Active Pharmaceutical Ingredient Excipient Sales Market Share in Volume by Type in 2025
Figure 14. Europe Active Pharmaceutical Ingredient Excipient Sales Market Share in Value by Type in 2025
Figure 15. Asia-Pacific Active Pharmaceutical Ingredient Excipient Sales Market Share in Volume by Type in 2025
Figure 16. Asia-Pacific Active Pharmaceutical Ingredient Excipient Sales Market Share in Value by Type in 2025
Figure 17. Latin America Active Pharmaceutical Ingredient Excipient Sales Market Share in Volume by Type in 2025
Figure 18. Latin America Active Pharmaceutical Ingredient Excipient Sales Market Share in Value by Type in 2025
Figure 19. Middle East and Africa Active Pharmaceutical Ingredient Excipient Sales Market Share in Volume by Type in 2025
Figure 20. Middle East and Africa Active Pharmaceutical Ingredient Excipient Sales Market Share in Value by Type in 2025
Figure 21. Global Top 5 and 10 Active Pharmaceutical Ingredient Excipient Players Market Share by Revenue in 2025
Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 23. Topical Formulations Image
Figure 24. Global Topical Formulations Sales YoY Growth (2021-2032) & (Kg)
Figure 25. Oral Formulations Image
Figure 26. Global Oral Formulations Sales YoY Growth (2021-2032) & (Kg)
Figure 27. Parenteral Formulations Image
Figure 28. Global Parenteral Formulations Sales YoY Growth (2021-2032) & (Kg)
Figure 29. Other Image
Figure 30. Global Other Sales YoY Growth (2021-2032) & (Kg)
Figure 31. Global Active Pharmaceutical Ingredient Excipient Market Size Overview by Application (2021-2032) & (US$ Million)
Figure 32. Global Active Pharmaceutical Ingredient Excipient Market Share by Application 2025 VS 2032
Figure 33. North America Active Pharmaceutical Ingredient Excipient Sales Market Share in Volume by Application in 2025
Figure 34. North America Active Pharmaceutical Ingredient Excipient Sales Market Share in Value by Application in 2025
Figure 35. Europe Active Pharmaceutical Ingredient Excipient Sales Market Share in Volume by Application in 2025
Figure 36. Europe Active Pharmaceutical Ingredient Excipient Sales Market Share in Value by Application in 2025
Figure 37. Asia-Pacific Active Pharmaceutical Ingredient Excipient Sales Market Share in Volume by Application in 2025
Figure 38. Asia-Pacific Active Pharmaceutical Ingredient Excipient Sales Market Share in Value by Application in 2025
Figure 39. Latin America Active Pharmaceutical Ingredient Excipient Sales Market Share in Volume by Application in 2025
Figure 40. Latin America Active Pharmaceutical Ingredient Excipient Sales Market Share in Value by Application in 2025
Figure 41. Middle East and Africa Active Pharmaceutical Ingredient Excipient Sales Market Share in Volume by Application in 2025
Figure 42. Middle East and Africa Active Pharmaceutical Ingredient Excipient Sales Market Share in Value by Application in 2025
Figure 43. North America Active Pharmaceutical Ingredient Excipient Sales by Country: 2021 VS 2025 VS 2032 (Kg)
Figure 44. North America Active Pharmaceutical Ingredient Excipient Sales Share by Country: 2021 VS 2025 VS 2032
Figure 45. North America Active Pharmaceutical Ingredient Excipient Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 46. North America Active Pharmaceutical Ingredient Excipient Market Share by Country: 2021 VS 2025 VS 2032
Figure 47. Europe Active Pharmaceutical Ingredient Excipient Sales by Country: 2021 VS 2025 VS 2032 (Kg)
Figure 48. Europe Active Pharmaceutical Ingredient Excipient Sales Share by Country: 2021 VS 2025 VS 2032
Figure 49. Europe Active Pharmaceutical Ingredient Excipient Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 50. Europe Active Pharmaceutical Ingredient Excipient Market Share by Country: 2021 VS 2025 VS 2032
Figure 51. Asia-Pacific Active Pharmaceutical Ingredient Excipient Sales by Country: 2021 VS 2025 VS 2032 (Kg)
Figure 52. Asia-Pacific Active Pharmaceutical Ingredient Excipient Sales Share by Country: 2021 VS 2025 VS 2032
Figure 53. Asia-Pacific Active Pharmaceutical Ingredient Excipient Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 54. Asia-Pacific Active Pharmaceutical Ingredient Excipient Market Share by Country: 2021 VS 2025 VS 2032
Figure 55. Latin America Active Pharmaceutical Ingredient Excipient Sales by Country: 2021 VS 2025 VS 2032 (Kg)
Figure 56. Latin America Active Pharmaceutical Ingredient Excipient Sales Share by Country: 2021 VS 2025 VS 2032
Figure 57. Latin America Active Pharmaceutical Ingredient Excipient Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 58. Latin America Active Pharmaceutical Ingredient Excipient Market Share by Country: 2021 VS 2025 VS 2032
Figure 59. Middle East and Africa Active Pharmaceutical Ingredient Excipient Sales by Country: 2021 VS 2025 VS 2032 (Kg)
Figure 60. Middle East and Africa Active Pharmaceutical Ingredient Excipient Sales Share by Country: 2021 VS 2025 VS 2032
Figure 61. Middle East and Africa Active Pharmaceutical Ingredient Excipient Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 62. Middle East and Africa Active Pharmaceutical Ingredient Excipient Market Share by Country: 2021 VS 2025 VS 2032
Figure 63. Active Pharmaceutical Ingredient Excipient Value Chain
Figure 64. Key Raw Materials Price
Figure 65. Manufacturing Cost Structure
Figure 66. Active Pharmaceutical Ingredient Excipient Production Mode & Process
Figure 67. Direct Comparison with Distribution Share
Figure 68. Distributors Profiles
Figure 69. Years Considered
Figure 70. Research Process
Figure 71. Key Executives Interviewed
Scope & coverage.
Types
- Synthetic Chemical APIs
- Natural Chemical APIs
Applications
- Topical Formulations
- Oral Formulations
- Parenteral Formulations
- Other
Companies covered
- BASF
- Roquette Freres
- DuPont
- Dow
- Croda Health Care
- Colorcon
- Ashland
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Active Pharmaceutical Ingredient Excipient Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Active Pharmaceutical Ingredient Excipient Sales Estimates and Forecasts (2021-2032)
- 1.3 Active Pharmaceutical Ingredient Excipient Market by Type
- 1.3.1 Synthetic Chemical APIs
- 1.3.2 Natural Chemical APIs
- 1.4 Global Active Pharmaceutical Ingredient Excipient Market Size by Type
- 1.4.1 Global Active Pharmaceutical Ingredient Excipient Market Size Overview by Type (2021-2032)
- 1.4.2 Global Active Pharmaceutical Ingredient Excipient Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Active Pharmaceutical Ingredient Excipient Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Active Pharmaceutical Ingredient Excipient Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Active Pharmaceutical Ingredient Excipient Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Active Pharmaceutical Ingredient Excipient Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Active Pharmaceutical Ingredient Excipient Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Active Pharmaceutical Ingredient Excipient Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Active Pharmaceutical Ingredient Excipient Industry Trends
- 2.2 Active Pharmaceutical Ingredient Excipient Industry Drivers
- 2.3 Active Pharmaceutical Ingredient Excipient Industry Opportunities and Challenges
- 2.4 Active Pharmaceutical Ingredient Excipient Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Active Pharmaceutical Ingredient Excipient Revenue (2021-2026)
- 3.2 Global Top Players by Active Pharmaceutical Ingredient Excipient Sales (2021-2026)
- 3.3 Global Top Players by Active Pharmaceutical Ingredient Excipient Price (2021-2026)
- 3.4 Global Active Pharmaceutical Ingredient Excipient Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Active Pharmaceutical Ingredient Excipient Major Company Production Sites & Headquarters
- 3.6 Global Active Pharmaceutical Ingredient Excipient Company, Product Type & Application
- 3.7 Global Active Pharmaceutical Ingredient Excipient Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Active Pharmaceutical Ingredient Excipient Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Active Pharmaceutical Ingredient Excipient Players Market Share by Revenue in 2025
- 3.8.3 2025 Active Pharmaceutical Ingredient Excipient Tier 1, Tier 2, and Tier 3
4 Active Pharmaceutical Ingredient Excipient Regional Status and Outlook
- 4.1 Global Active Pharmaceutical Ingredient Excipient Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Active Pharmaceutical Ingredient Excipient Historic Market Size by Region
- 4.2.1 Global Active Pharmaceutical Ingredient Excipient Sales in Volume by Region (2021-2026)
- 4.2.2 Global Active Pharmaceutical Ingredient Excipient Sales in Value by Region (2021-2026)
- 4.2.3 Global Active Pharmaceutical Ingredient Excipient Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Active Pharmaceutical Ingredient Excipient Forecasted Market Size by Region
- 4.3.1 Global Active Pharmaceutical Ingredient Excipient Sales in Volume by Region (2027-2032)
- 4.3.2 Global Active Pharmaceutical Ingredient Excipient Sales in Value by Region (2027-2032)
- 4.3.3 Global Active Pharmaceutical Ingredient Excipient Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Active Pharmaceutical Ingredient Excipient by Application
- 5.1 Active Pharmaceutical Ingredient Excipient Market by Application
- 5.1.1 Topical Formulations
- 5.1.2 Oral Formulations
- 5.1.3 Parenteral Formulations
- 5.1.4 Other
- 5.2 Global Active Pharmaceutical Ingredient Excipient Market Size by Application
- 5.2.1 Global Active Pharmaceutical Ingredient Excipient Market Size Overview by Application (2021-2032)
- 5.2.2 Global Active Pharmaceutical Ingredient Excipient Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Active Pharmaceutical Ingredient Excipient Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Active Pharmaceutical Ingredient Excipient Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Active Pharmaceutical Ingredient Excipient Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Active Pharmaceutical Ingredient Excipient Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Active Pharmaceutical Ingredient Excipient Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Active Pharmaceutical Ingredient Excipient Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 BASF
- 6.1.1 BASF Company Information
- 6.1.2 BASF Business Overview
- 6.1.3 BASF Active Pharmaceutical Ingredient Excipient Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 BASF Active Pharmaceutical Ingredient Excipient Product Portfolio
- 6.1.5 BASF Recent Developments
- 6.2 Roquette Freres
- 6.2.1 Roquette Freres Company Information
- 6.2.2 Roquette Freres Business Overview
- 6.2.3 Roquette Freres Active Pharmaceutical Ingredient Excipient Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Roquette Freres Active Pharmaceutical Ingredient Excipient Product Portfolio
- 6.2.5 Roquette Freres Recent Developments
- 6.3 DuPont
- 6.3.1 DuPont Company Information
- 6.3.2 DuPont Business Overview
- 6.3.3 DuPont Active Pharmaceutical Ingredient Excipient Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 DuPont Active Pharmaceutical Ingredient Excipient Product Portfolio
- 6.3.5 DuPont Recent Developments
- 6.4 Dow
- 6.4.1 Dow Company Information
- 6.4.2 Dow Business Overview
- 6.4.3 Dow Active Pharmaceutical Ingredient Excipient Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Dow Active Pharmaceutical Ingredient Excipient Product Portfolio
- 6.4.5 Dow Recent Developments
- 6.5 Croda Health Care
- 6.5.1 Croda Health Care Company Information
- 6.5.2 Croda Health Care Business Overview
- 6.5.3 Croda Health Care Active Pharmaceutical Ingredient Excipient Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Croda Health Care Active Pharmaceutical Ingredient Excipient Product Portfolio
- 6.5.5 Croda Health Care Recent Developments
- 6.6 Colorcon
- 6.6.1 Colorcon Company Information
- 6.6.2 Colorcon Business Overview
- 6.6.3 Colorcon Active Pharmaceutical Ingredient Excipient Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Colorcon Active Pharmaceutical Ingredient Excipient Product Portfolio
- 6.6.5 Colorcon Recent Developments
- 6.7 Ashland
- 6.7.1 Ashland Company Information
- 6.7.2 Ashland Business Overview
- 6.7.3 Ashland Active Pharmaceutical Ingredient Excipient Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Ashland Active Pharmaceutical Ingredient Excipient Product Portfolio
- 6.7.5 Ashland Recent Developments
7 North America by Country
- 7.1 North America Active Pharmaceutical Ingredient Excipient Sales by Country
- 7.1.1 North America Active Pharmaceutical Ingredient Excipient Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Active Pharmaceutical Ingredient Excipient Sales by Country (2021-2026)
- 7.1.3 North America Active Pharmaceutical Ingredient Excipient Sales Forecast by Country (2027-2032)
- 7.2 North America Active Pharmaceutical Ingredient Excipient Market Size by Country
- 7.2.1 North America Active Pharmaceutical Ingredient Excipient Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Active Pharmaceutical Ingredient Excipient Market Size by Country (2021-2026)
- 7.2.3 North America Active Pharmaceutical Ingredient Excipient Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Active Pharmaceutical Ingredient Excipient Sales by Country
- 8.1.1 Europe Active Pharmaceutical Ingredient Excipient Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Active Pharmaceutical Ingredient Excipient Sales by Country (2021-2026)
- 8.1.3 Europe Active Pharmaceutical Ingredient Excipient Sales Forecast by Country (2027-2032)
- 8.2 Europe Active Pharmaceutical Ingredient Excipient Market Size by Country
- 8.2.1 Europe Active Pharmaceutical Ingredient Excipient Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Active Pharmaceutical Ingredient Excipient Market Size by Country (2021-2026)
- 8.2.3 Europe Active Pharmaceutical Ingredient Excipient Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Active Pharmaceutical Ingredient Excipient Sales by Country
- 9.1.1 Asia-Pacific Active Pharmaceutical Ingredient Excipient Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Active Pharmaceutical Ingredient Excipient Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Active Pharmaceutical Ingredient Excipient Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Active Pharmaceutical Ingredient Excipient Market Size by Country
- 9.2.1 Asia-Pacific Active Pharmaceutical Ingredient Excipient Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Active Pharmaceutical Ingredient Excipient Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Active Pharmaceutical Ingredient Excipient Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Active Pharmaceutical Ingredient Excipient Sales by Country
- 10.1.1 South America Active Pharmaceutical Ingredient Excipient Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Active Pharmaceutical Ingredient Excipient Sales by Country (2021-2026)
- 10.1.3 South America Active Pharmaceutical Ingredient Excipient Sales Forecast by Country (2027-2032)
- 10.2 South America Active Pharmaceutical Ingredient Excipient Market Size by Country
- 10.2.1 South America Active Pharmaceutical Ingredient Excipient Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Active Pharmaceutical Ingredient Excipient Market Size by Country (2021-2026)
- 10.2.3 South America Active Pharmaceutical Ingredient Excipient Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Active Pharmaceutical Ingredient Excipient Sales by Country
- 11.1.1 Middle East and Africa Active Pharmaceutical Ingredient Excipient Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Active Pharmaceutical Ingredient Excipient Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Active Pharmaceutical Ingredient Excipient Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Active Pharmaceutical Ingredient Excipient Market Size by Country
- 11.2.1 Middle East and Africa Active Pharmaceutical Ingredient Excipient Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Active Pharmaceutical Ingredient Excipient Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Active Pharmaceutical Ingredient Excipient Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Active Pharmaceutical Ingredient Excipient Value Chain Analysis
- 12.1.1 Active Pharmaceutical Ingredient Excipient Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Active Pharmaceutical Ingredient Excipient Production Mode & Process
- 12.2 Active Pharmaceutical Ingredient Excipient Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Active Pharmaceutical Ingredient Excipient Distributors
- 12.2.3 Active Pharmaceutical Ingredient Excipient Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,450USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst